Medical laboratory technology information

Medical laboratory technology information Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Medical laboratory technology information, Agartala.

🔬 Medical Laboratory Technology | 🧬 The science behind every diagnosis. 🩸 Sharing knowledge on Hematology, Microbiology, Biochemistry & more. 🧪 Educational content for MLT students and professionals. 📚 Learn • Explore • Share • Grow ❤️

14/10/2026
13/10/2026
🌹 Blood Product Components in Blood Bank🌹 Red Blood Cell Components🌹✅ PRC (Packed Red Cells)🩸 Concentrated red blood cel...
13/10/2026

🌹 Blood Product Components in Blood Bank

🌹 Red Blood Cell Components🌹
✅ PRC (Packed Red Cells)
🩸 Concentrated red blood cells used to improve oxygen delivery to tissues in patients with anemia or blood loss, according to clinical indications.

✅ LPRC (Leukocyte-Poor Red Cells)
🩸 Red blood cells with a reduced leukocyte count. They may help reduce the risk of certain transfusion reactions, such as Febrile Non-Hemolytic Transfusion Reaction (FNHTR). Their effectiveness depends on the product preparation process and the degree of leukocyte reduction.

✅ LDPRC (Leukodepleted Packed Red Cells)
🩸 Packed red blood cells that have undergone leukocyte reduction according to standard criteria. They help reduce the risk of FNHTR, HLA alloimmunization, and leukocyte-associated Cytomegalovirus (CMV) transmission, but these risks cannot be completely eliminated.

💐 Plasma Components💐
✅ FFP (Fresh Frozen Plasma)
❄️ Plasma frozen within the specified time after blood collection to preserve coagulation factors. It is used to replace multiple coagulation factors in patients with clinical indications.

✅ LDFFP (Leukodepleted Fresh Frozen Plasma)
❄️ Fresh frozen plasma that has undergone leukocyte reduction according to product specifications, with coagulation factors meeting the specified quality criteria.

🩺 Clinical Use
Used to replace multiple coagulation factors in patients with clinical indications, based on coagulation factor deficiencies, the severity of bleeding, and appropriate treatment guidelines.

✅ Cryoprecipitate
🧬 A plasma component containing high concentrations of certain proteins and coagulation factors, including:
🩸 Fibrinogen (Factor I): An essential precursor for clot formation.
🩸 Factor VIII: An important factor in the blood coagulation process.
🩸 von Willebrand factor (vWF): Helps platelets adhere to injured blood vessel walls and stabilizes Factor VIII.
🩸 Factor XIII: Helps strengthen and stabilize blood clots.
🩸 Fibronectin: A protein involved in cell adhesion and tissue repair.

🩺 Clinical Use
Used to replace fibrinogen in patients with low fibrinogen levels and clinical indications, according to treatment guidelines and the availability of appropriate products.

🌺 Platelet Components🌺
✅ PC (Platelet Concentrate)
🩸 Random PC (Platelet Concentrate)
Platelets separated from a single blood donor. Each unit has a relatively small volume and contains some leukocytes. For adult patients, platelets from multiple donors are commonly pooled, usually around 4–6 units.

⚠️ Open System
After pooling, the product must be used within the time specified by the applicable standards, generally no longer than 4 hours.

🩺 Clinical Use
Used to prevent or treat bleeding in patients with low platelet counts or platelet function disorders, according to clinical indications.

✅ LPPC (Leukocyte-Poor Platelet Concentrate)
🩸 Platelet concentrates with a reduced leukocyte count.
These products undergo a process to reduce leukocytes. The Buffy Coat layers from 4–6 donors of the same blood group are often pooled and centrifuged again. The leukocyte count is reduced to some extent, but some leukocytes remain, potentially at higher levels than in LDPPC.

🩺 Clinical Use
Used to prevent or treat bleeding in patients with indications for platelet transfusion. Leukocyte reduction may help reduce the risk of FNHTR and HLA alloimmunization. The effectiveness depends on the degree of leukocyte reduction in the product.

✅ LDPPC (Leukodepleted Pooled Platelet Concentrates)
🩸 Pooled platelet concentrates that have undergone leukocyte reduction.
A specialized leukocyte filter is used after pooling to remove leukocytes, leaving only a very small number. This product undergoes a high degree of leukocyte reduction.

🩺 Clinical Use
Used to prevent or treat bleeding in patients with indications for platelet transfusion. Leukocyte reduction helps reduce the risk of FNHTR and HLA alloimmunization, but it does not eliminate all leukocytes or prevent every type of transfusion reaction.

✅ SDP (Single Donor Platelets)
🩸 Platelets collected from a single donor.
Platelets are collected from one donor using an Apheresis machine. One adult unit generally provides a platelet dose comparable to several units of platelets derived from whole-blood donations, depending on the platelet content of the product.

🩺 Clinical Use
Used to prevent or treat bleeding in patients with clinical indications.

✅ LDSDP (Leukodepleted Single Donor Platelets)
🩸 Single-donor platelets that have undergone leukocyte reduction.
Platelets collected from a single donor using an Apheresis machine and processed to reduce leukocytes according to product specifications.

🩺 Clinical Use
Used to prevent or treat bleeding in patients with clinical indications. Leukocyte reduction helps reduce the risk of FNHTR and HLA alloimmunization, but it cannot eliminate all transfusion-related risks.

🌡️ Platelet Storage
Platelets must be stored at the temperature and un

13/10/2026
🧪 Blood Collection Tubes and Their Common Lab TestsDo you know which blood collection tube is required for each laborato...
12/10/2026

🧪 Blood Collection Tubes and Their Common Lab Tests

Do you know which blood collection tube is required for each laboratory test?

🔬 Gold: Chemistry tests, including LFTs and renal function tests
🔵 Light Blue: PT/INR, aPTT, fibrinogen, and D-dimer
🟢 Green: Plasma chemistry and selected STAT tests
🟣 Lavender: CBC, differential, and HbA1c
⚪ Grey: Glucose testing and selected lactate tests
🔴 Red: Serum testing, depending on tube type
🩷 Pink: Blood grouping, antibody screening, and crossmatch
🧫 Blood Culture Bottles: Detection of bloodstream infections

⚠️ Remember: Tube additives and test requirements vary. Always follow your laboratory’s test directory and SOP.

Which tube do you find most confusing in daily laboratory practice?

💐 Hematology & Blood Bank 💐❤️ One Goal: Patient Safety ❤️💐 The Hematology and Blood Bank departments play important role...
12/10/2026

💐 Hematology & Blood Bank 💐

❤️ One Goal: Patient Safety ❤️

💐 The Hematology and Blood Bank departments play important roles in supporting accurate diagnosis, appropriate treatment, and safe blood component transfusion. The collaboration between these two departments relies on laboratory results interpreted together with each patient's clinical condition to ensure appropriate and safe patient care.

💐 The Connection Between Hematology and Blood Bank
✅ 1. Complete Blood Count (CBC)
CBC testing is used to assess:
🔸 Hemoglobin (Hb)
🔸 Hematocrit (Hct)
🔸 Platelet count
These results support the assessment of anemia, thrombocytopenia, and the need for blood component transfusion according to clinical indications.
✅ 2. Antibody Screening & Crossmatch
🔸 Antibody Screening helps detect clinically significant red blood cell antibodies.
🔸 Crossmatch testing is used to assess compatibility between donor and recipient blood according to established criteria.
Both tests are particularly important in patients who require repeated blood transfusions, such as patients with thalassemia, who may have an increased risk of developing antibodies against red blood cell antigens due to transfusion exposure.
✅ 3.Post Transfusion Monitoring
The response to blood transfusion should be monitored through clinical assessment and laboratory testing when indicated, such as:
🔸 Hb/Hct testing after red blood cell transfusion.
🔸 Platelet count testing after platelet transfusion.

💐 Indications for Blood Component Transfusion
🌺 1. LPRC
Used in patients with anemia or blood loss when there is a clinical indication to increase the oxygen-carrying capacity of the blood.
The decision to transfuse blood should consider the Hb level, clinical symptoms, vital signs, hemodynamic status, and the patient's comorbidities. The hemoglobin level alone should not be used to determine the need for transfusion.
🌺 2. FFP (Fresh Frozen Plasma)
🔸 Used to replace coagulation factors in patients with bleedi

Address

Agartala

Website

Alerts

Be the first to know and let us send you an email when Medical laboratory technology information posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share